Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $293.7400 (-0.3%) ($292.5000 - $295.5688) on Sat. May. 26, 2018. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 1.81% (three month average) | | RSI | 57 | | Latest Price | $293.7400(-0.3%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -0.5% a day on average for past five trading days. | | Weekly Trend | REGN advances 0.4% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
(0%) (0%) (0%) (0%) (0%) | | Factors Impacting REGN price | REGN will decline at least -0.905% in a week (0% probabilities).
(0%) (0%) (0%) (0%) (0%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.905% (StdDev 1.81%) | | Hourly BBV | 0 () | | Intraday Trend | -0.1% | | | | | |
|
| Resistance Level | $296.92 | | 5 Day Moving Average | $294.99(-0.42%) | | 10 Day Moving Average | $299.5(-1.92%) | | 20 Day Moving Average | $296.92(-1.07%) | | To recent high | -14.7% | | To recent low | 3.2% | | Market Cap | $N/A | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |